Literature DB >> 8930335

Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.

T Belej1, D Manji, S Sioutis, H M Barros, J N Nobrega.   

Abstract

Although acute cocaine is a strong reuptake inhibitor at dopamine (DA), norepinephrine (NE) and serotonin (5-HT) synapses, the effects of chronic cocaine on 5-HT and NE transporters have received less attention than its effects on DA transporters. In the present study, quantitative autoradiography was used to map effects of chronic cocaine exposure on the binding of [3H]nisoxetine and [3H]cyanoimipramine to NE and 5-HT transporters, respectively. Female Wistar rats were given increasing concentrations of cocaine in the drinking water for 4 weeks (mean dose during the final two weeks: approximately 25 mg/kg body weight) and sacrificed either on the 30th day of cocaine administration or at one of two time points after withdrawal (4 days or 30 days). In animals sacrificed while on cocaine. [3H]cyanoimipramine binding was significantly elevated in the infralimbic cortex (+13%, P < 0.05), n. accumbens (+16%, P < 0.05, P < 0.05), lateral septal n. (+21%, P < 0.05), pedunculopontine n. (+16%, P < 0.05), and vestibular n. (+19%, P < 0.05). These changes were no longer observed when brains were examined either 4 days or 30 days after cessation of cocaine. In animals sacrificed while on cocaine, [3H]nisoxetine binding was decreased in the bed n. of the stria terminalis (-18%, P < 0.05), the lateral parabrachial area (-35%, P < 0.05) and the inferior olive (-26%, P < 0.05). In animals sacrificed 4 days after cessation of cocaine, these effects were no longer apparent, except for a 16% reduction in the inferior olive (P < 0.05). In this 4-day withdrawal group, a significant increase in [3H]nisoxetine binding was seen in the paraventricular n. of the hypothalamus (PVN, +33%, P < 0.05). This PVN change was still seen in the group sacrificed 30 days after cessation of cocaine (+44%, P < 0.02). Binding of [3H]WIN 35,428 to dopamine transporters was unaltered in this group. Taken together, these observations indicate that chronic cocaine has different effects on brain 5-HT and NE transporters, both while the animals are on cocaine and after withdrawal. They support the notion that increased 5-HT uptake in limbic forebrain may play a role in behavioral/psychiatric effects of chronic cocaine. They are also consistent with previous indications that chronic cocaine does not induce degeneration of nerve terminals in noradrenergic or serotonergic neurons. The persistent increase in [3H]nisoxetine binding in the paraventricular hypothalamus suggests the possibility of neuroendocrine changes after withdrawal from chronic cocaine use.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930335     DOI: 10.1016/0006-8993(96)00713-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Dopaminergic reward system: a short integrative review.

Authors:  Oscar Arias-Carrión; Maria Stamelou; Eric Murillo-Rodríguez; Manuel Menéndez-González; Ernst Pöppel
Journal:  Int Arch Med       Date:  2010-10-06

2.  Involvement of noradrenergic neurotransmission in the stress- but not cocaine-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors.

Authors:  John R Mantsch; Andy Weyer; Oliver Vranjkovic; Chad E Beyer; David A Baker; Holly Caretta
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

Review 3.  Kappa opioids as potential treatments for stimulant dependence.

Authors:  Thomas E Prisinzano; Kevin Tidgewell; Wayne W Harding
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

4.  Serotonin transporter protein in autopsied brain of chronic users of cocaine.

Authors:  Junchao Tong; Jeffrey H Meyer; Isabelle Boileau; Lee-Cyn Ang; Paul J Fletcher; Yoshiaki Furukawa; Stephen J Kish
Journal:  Psychopharmacology (Berl)       Date:  2020-06-03       Impact factor: 4.530

5.  Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans.

Authors:  Xingguang Luo; Henry R Kranzler; Lingjun Zuo; Shuang Wang; Nicholas J Schork; Joel Gelernter
Journal:  Hum Mol Genet       Date:  2006-12-21       Impact factor: 6.150

6.  Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain.

Authors:  Thomas J R Beveridge; Hilary R Smith; Michael A Nader; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

7.  Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways.

Authors:  L K Vaughn; J R Mantsch; O Vranjkovic; G Stroh; M Lacourt; M Kreutter; C J Hillard
Journal:  Neuroscience       Date:  2011-08-16       Impact factor: 3.590

8.  Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats.

Authors:  Deanne M Buffalari; Chelsey K Baldwin; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2012-04-18       Impact factor: 4.530

9.  Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.

Authors:  Marta Valenza; Kyle A Windisch; Eduardo R Butelman; Brian Reed; Mary Jeanne Kreek
Journal:  Psychopharmacology (Berl)       Date:  2020-01-08       Impact factor: 4.530

10.  High-fat diet-induced alterations in the feeding suppression of low-dose nisoxetine, a selective norepinephrine reuptake inhibitor.

Authors:  Nicholas T Bello; Amy L Walters; Jessica L Verpeut; Priscila P Cunha
Journal:  J Obes       Date:  2013-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.